IMMUNOTHERAPY FOR STEWART-TREVES SYNDROME - USEFULNESS OF INTRAPLEURAL ADMINISTRATION OF TUMOR-INFILTRATING LYMPHOCYTES AGAINST MASSIVE PLEURAL EFFUSION CAUSED BY METASTATIC ANGIOSARCOMA
M. Furue et al., IMMUNOTHERAPY FOR STEWART-TREVES SYNDROME - USEFULNESS OF INTRAPLEURAL ADMINISTRATION OF TUMOR-INFILTRATING LYMPHOCYTES AGAINST MASSIVE PLEURAL EFFUSION CAUSED BY METASTATIC ANGIOSARCOMA, Journal of the American Academy of Dermatology, 30(5), 1994, pp. 899-903
We describe a 56-year-old woman with Stewart-Treves syndrome who had s
evere dyspnea from a pleural effusion caused by metastatic angiosarcom
a in the right lung. Tumorinfiltrating lymphocytes (TIL) in the pleura
l effusion were cultured and expanded in vitro in the continuous prese
nce of recombinant interleukin 2 with periodic stimulation by CD3 anti
body. The expanded TIL were administered intrapleurally seven times at
1- to 4-week intervals in combination with intravenous infusion of re
combinant interleukin 2. A panel of T-cell clones was also obtained fr
om TIL. Immunotherapy dramatically improved the patient's dyspnea and
pleural effusion. A CD4(+) T-cell clone and a CD8(+) T-cell clone esta
blished from TIL had specific cytotoxicity to the tumor cells.